Abstract: One embodiment provides a method for enzymatic treatment, including the steps of forming a closed space on a local tissue area with a device and infusing an enzyme solution into the closed space for enzymatic treatment. The method according to the embodiment is capable of treating the local tissue area with enzymes for enhancing cell proliferation in the treated tissue area and preventing damage of the adjacent normal tissues. A device and kit used for the method are also provided.
Type:
Grant
Filed:
September 13, 2012
Date of Patent:
March 18, 2014
Assignee:
Industrial Technology Research Institute
Abstract: Process for preserving insulin secreting cells intended to be transplanted, including the following steps: introducing an initial volume of culture medium and insulin-secreting cells into a culture container, providing a culture medium source, and replacing, at time intervals below 8 hours, the culture medium in the culture container with culture medium from the source so as to renew the culture medium contained in the container.
Type:
Grant
Filed:
May 15, 2009
Date of Patent:
February 4, 2014
Assignees:
Maco Pharma, Centre Hospitalier Regional Universitaire de Lille, Universite du Droit et de la Sante de Lille 2
Inventors:
Francois Pattou, Julie Kerr-Conte, Cecile Coissac Blondel, Bruno Lukowiak, Brigitte Vandewalle, Antoine Heron
Abstract: A method for treating an organic and/or inorganic substrate utilizing a granular material made of a solid foam as support for an active component, for example a biocatalyst such as a microorganism or an enzyme. The solid foam has a continuous phase in which magnetizable particles are embedded, such that the support with the biologically active component immobilized thereon can be separated from a mixture with a magnetic separation device.
Type:
Grant
Filed:
February 8, 2013
Date of Patent:
January 28, 2014
Assignee:
SUED-Chemie IP GmbH & Co. KG
Inventors:
Friedrich Ruf, Ulrich Sohling, Elisabeth Neitmann, Bernd Linke, Jan Mumme, Patrice Ramm, Oliver Menhorn, Karl Weinberger, Peter Kumpf
Abstract: A method for producing biomass and sequestering greenhouse gas includes providing a greenhouse gas, providing light energy, and growing algae in a growth container with the greenhouse gas and the light energy. The algae can be processed into a biomass feedstock. The biomass feedstock can be converted into a fuel or specialty chemical. At least a portion of the algae can be used as a fertilizer for a biomass growth source.
Abstract: The disclosure provides methods and compositions useful for culturing stem cell including embryonic stem cells, adult stem cells, and embryonic germ cells.
Type:
Grant
Filed:
April 13, 2010
Date of Patent:
December 17, 2013
Assignee:
The Regents of the University of California
Abstract: A process for fermenting syngas is provided which is effective for decreasing an amount of time needed to inoculate a main reactor. The process includes propagating a culture of acetogenic bacteria to provide an inoculum for a main reactor and fermenting syngas in the main reactor.
Abstract: A method for moving a probe (10, 91) through a cell material (20), which is formed from biological cells (21), is described, the probe (10) displacing the cells (21) without injury. A probe (10, 91) for performing the method and a cell manipulator, which is equipped with at least one probe of this type, are also described.
Type:
Grant
Filed:
December 2, 2003
Date of Patent:
November 19, 2013
Assignee:
Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung E.V.
Abstract: The object of the present invention is to provide a technique to inhibit methanogens from producing methane. The use of Alcaligenes faecalis can inhibit methanogens from producing methane.
Abstract: Methods for determining whether a cancer patient is likely to benefit from treatment with a taxane compound based on Akt-Ser473 phosphorylation status are provided, together with kits for determining Akt-Ser473 phosphorylation status and methods for improving treatment of a cancer patient that include obtaining a determination of the Akt-Ser473 phosphorylation status of the cancer.
Type:
Grant
Filed:
May 21, 2010
Date of Patent:
October 1, 2013
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human Services